Skip Navigation

Annals of Oncology 2007 18(9):1427; doi:10.1093/annonc/mdm421
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Ann Oncol
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

in this issue

In this issue

The first 10% of the full text of this article appears below.


   Breast cancer classification and chemotherapy
 
A large proportion of breast cancer patients do not benefit from treatment with adjuvant chemotherapy, and the need has emerged to identify predictive biomarkers that can recognize these patients. Estrogen receptor (ER) expression has been reported as a predictive factor for the efficacy of adjuvant methotrexate- or paclitaxel-based chemotherapy, and several papers have reported that ER expression correlates with resistance to preoperative anthracycline-based chemotherapy. Nevertheless, there . . . [Full Text of this Article]


   Colonoscopy in first-degree relatives of colorectal cancer patients
 

   Polymorphisms in acute myeloid leukemia
 

   Synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models
 

   Quote
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Ann Oncol:

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials
R Conforti, T Boulet, G Tomasic, E Taranchon, R Arriagada, M Spielmann, M Ducourtieux, JC Soria, T Tursz, S Delaloge, S Michiels, and F Andre
Ann Oncol 2007 18: 1477-1483. [Abstract] [FREE Full Text]  

Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer
F Ruthotto, F Papendorf, G Wegener, G Unger, B Dlugosch, F Korangy, MP Manns, and TF Greten
Ann Oncol 2007 18: 1518-1522. [Abstract] [FREE Full Text]  

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes
MT Voso, E Fabiani, F D'Alo', F Guidi, A Di Ruscio, S Sica, L Pagano, M Greco, S Hohaus, and G Leone
Ann Oncol 2007 18: 1523-1528. [Abstract] [FREE Full Text]  

Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models
C Pisano, L Vesci, R Foderà, FF Ferrara, C Rossi, M De Cesare, V Zuco, G Pratesi, R Supino, and F Zunino
Ann Oncol 2007 18: 1500-1505. [Abstract] [FREE Full Text]